Navigation Links
Regenicin CEO to Speak at LifeTech Investor Conference in Miami, Florida November 12th, 2010
Date:11/12/2010

NEW YORK, Nov. 12, 2010 /PRNewswire-FirstCall/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs, will be represented by company CEO, Randall McCoy at the 1st Annual LifeTech Investor Conference at the JW Marriott Marquis today in Miami.

Mr. McCoy will present Regenicin's core concept and business model for bringing regenerative medicine products to market.  Regenicin will be among twenty four public biotechnology and medical technology companies that will be presenting to institutional and private investors.

In addition to Regenicin, the conference will feature the University of Miami Miller School of Medicine Technology Showcase as well as panels of experts from their renowned centers such as the Sylvester Cancer Center, the Bascom Palmer Eye Institute and the Stem Cell Institute. For more information and free registration, visit http://www.LifeTechCapital.com/conference.

About Regenicin

Regenicin, Inc. is a development stage biotechnology company. Regenicin is a publicly traded company, with headquarters in New York. Additional information can be found in the company's filings with the Securities and Exchange Commission located at www.sec.gov.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expe
'/>"/>

SOURCE Regenicin(TM), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
2. Regenicin™ to Present at the Rodman & Renshaw Healthcare Conference
3. 38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
4. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
5. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
6. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
7. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
8. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
9. HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
10. Joint Commission Urges Patients to Speak Up About Pain
11. ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... MENLO PARK, Calif. , June ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... clinical trial of  VAL-083  (dianhydrogalactitol) in patients with ... deadly form of human brain cancer. ...
(Date:6/1/2015)... SAN DIEGO , June 1, 2015  Diomics, ... Richard M. Weissman , global financial executive, has ... Mr. Weissman has more than 25 years of industry ... Diomics, he served as a managing director at Credit ... UBS and Morgan Stanley/Dean Witter. "Diomics is ...
(Date:6/1/2015)... 1, 2015  AbbVie (NYSE: ABBV ) will ... June 4, 2015. Richard A. Gonzalez , chairman ... and answer session at 8:30 a.m. Central time. ... be accessible through AbbVie,s Investor Relations Web site at ... will be available later that day. ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8Richard M. Weissman joins Diomics Board of Directors 2
... SuccessEHS, a nationally recognized, streamlined practice management and ... ambulatory care software solution with a signature Success Architecture ... With this pairing, SuccessEHS is well-positioned to meet ... The essential technical, functional and reporting needs of a ...
... 21, 2011 Sheffield Bio-Science, a Kerry Group Business, ... alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science ... for recombinant insulin manufactured by global Indian biotech Wockhardt. ... is around US$ 50 million. Speaking on ...
Cached Medicine Technology:SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals 2SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals 3SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals 4Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market 2
(Date:6/1/2015)... Sharenote, a leading web-base electronic healthcare software ... this week in Louisiana. The entrepreneurial trio behind Sharenote, ... provide potential providers with the tools and resources to ... within their network. , Find out why Sharenote ... by more than 250 practices. , Four Day ...
(Date:6/1/2015)... June 01, 2015 KC and Monica ... $88,000 of the best superfood products in ... floods in Texas. , "Monica and I are ... News in distributing Living Fuel Super Meals - SuperBerry®, ... millennial floods in Texas," KC Craichy said. "We have ...
(Date:6/1/2015)... 2015 More than 22 million children may ... school is out and they lose access to free or ... dairy farmers and milk companies are on a mission to ... Great American Milk Drive. , In many cases, food ... school cafeteria for the bulk of their daily nutrition. Although ...
(Date:6/1/2015)... CA (PRWEB) June 01, 2015 ... Assili are now offering patients a promotion on Invisalign ... price of Invisalign treatment is reduced to $3,700. Patients ... during the complimentary consultation and discuss the extent of ... and it cannot be combined with any other offer. ...
(Date:6/1/2015)... Listen to Volvo’s Director of Connectivity ... using more granular data to create better customer oriented ... voices in Josep Celaya Gonzalez, CIO at MAPFRE, and ... an automotive insurer, MAPFRE are well versed in capturing ... to the driver. Award winning start-up ParkTAG offer an ...
Breaking Medicine News(10 mins):Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2
... consumption, study finds , , THURSDAY, Nov. 27 (HealthDay News) ... other sugar-sweetened drinks from school cafeteria menus will have ... , Because these drinks are believed to be ... in the United States, many schools across the nation ...
... Montreal, Canada, November 27, 2008 Suffering from ... at the Centre hospitalier de l,Universit de Montral (CHUM), ... high efficacy hemodiafiltration (HDF). , An extracorporeal blood ... the HDF unit was introduced in CHUM,s Nephrology section, ...
... inhibits bacterial growth, experts say , , THURSDAY, Nov. ... cranberry sauce on your plate this Thanksgiving, because it may ... the American Urological Association. , The high acid content ... remedy for simple UTIs, help inhibit bacterial growth along the ...
... 27 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.,(NYSE: ... medical device,research and development outsourcing company with operations ... Hu, the Company,s Chief Operating,Officer, will present at ... December 3, 2008, at 12:00 pm Eastern Standard ...
... auction special Pinot Noirs to benefit healthcare services for seasonal vineyard ... for 17 years, producers preview outstanding 2007 vintage. , ... ... Salud! The Oregon Pinot Noir Auction contributed generously to the 17th ...
... patients will benefit, researchers say , , WEDNESDAY, Nov. 26 (HealthDay ... with a certain type of non-Hodgkin lymphoma have a better ... , Three different signatures of gene activity, or ... gene -- have been identified in people with diffuse large ...
Cached Medicine News:Health News:School Soda Ban Has Limited Effect 2Health News:Major North American breakthrough for dialysis patients 2Health News:Major North American breakthrough for dialysis patients 3Health News:Cranberries May Help Prevent Urinary Tract Infections 2Health News:WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference 2Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 2Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 3Health News:Genes May Predict Lymphoma Treatment Outcome 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: